Heterogeneous Cell Types in Single-cell-derived Clones of MCF7 and MDA-MB-231 Cells
- PMID: 28476800
- DOI: 10.21873/anticanres.11572
Heterogeneous Cell Types in Single-cell-derived Clones of MCF7 and MDA-MB-231 Cells
Abstract
Background/aim: Variations in cell phenotype in a single-cell-derived clone may result from asymmetric cell divisions that lead to different cell fate in a homogenous microenvironment. The aim of this study was to demonstrate the extent of cell variety in single-cell-derived clones and propose a different strategy in treating cancer by observed phenotypic heterogeneity in cellular types. Additionally, the role of metabolic enzyme and housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), in cellular phenotype was evaluated in two breast cancer cell lines.
Materials and methods: Two GAPDH-overexpressing breast cancer cell lines, MCF7-GAPDH-RFP (MCF7-RFP) and MDA-MB-231-GAPDH-RFP (MDA-RFP), were established. Microscopic recordings were made at 12-h intervals in single-cell-derived clones of both cell lines up to 8-10 days. Crystal violet and Hoechst 33342 (Hoechst), as well as specific cell-type (epithelial and mesenchymal) antibodies, were used for cytochemical and immunohistochemical staining analyses, respectively, at 3, 6 and 9 days during cell growth.
Results: Three types of clones with distinct morphologies were identified as holo-, mero- and paraclones. The rates of colony survival during cell growth were 8.3 and 41.7% in MCF7-RFP and MDA-RFP, respectively. Although no significant difference was found in the colony forming efficiency (CFE) of both MCF7 and MDA-MD-231 wild-type cells, a markedly significant difference was seen in the CFE of MCF7-RFP and MDA-RFP cells (p=0.001). Wild-type cell-derived holoclones of both cell lines showed drug resistance to doxorubicin (Dox). However, levels of proliferating cell nuclear antigen (PCNA) and vimentin (VIM) marginally decreased in Dox-treated clones. Furthermore, high level of intraclonal heterogeneity was found for CD44, CD140a, VIM, fibronectin (FN), focal adhesion kinase (FAK), paxillin (PXN) and vinculin (VCL) in MCF7 and MDA clones during different stages of clonal development. Expressions of CD140a, FN, VIM and FAK were induced in GAPDH-red fluorescent protein (RFP)-tagged clones of both cell lines.
Conclusion: The GAPDH-RFP recombinant protein played an important role in morphological heterogeneity detection in early stages of clonal development. Moreover, phenotypic heterogeneity in clones, caused by the cells expressing specific antigens, such as CD44, CD140a, FN, VIM, FAK and VCL, can be the right target for therapeutic drugs.
Keywords: GAPDH; Heterogeneity; MCF7; MDA-MB-231; clonal analysis; surface markers.
Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Similar articles
-
Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.Anticancer Res. 2017 May;37(5):2355-2364. doi: 10.21873/anticanres.11573. Anticancer Res. 2017. PMID: 28476801
-
Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).Int J Cancer. 2007 Jan 1;120(1):181-8. doi: 10.1002/ijc.22187. Int J Cancer. 2007. PMID: 17036319
-
Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.Cell Biochem Biophys. 2009;55(2):95-105. doi: 10.1007/s12013-009-9058-3. Epub 2009 Jul 11. Cell Biochem Biophys. 2009. PMID: 19593673
-
Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.Oncogene. 2005 Nov 17;24(51):7542-51. doi: 10.1038/sj.onc.1208908. Oncogene. 2005. PMID: 16044152
-
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.Endocr Relat Cancer. 2013 Jan 7;20(1):1-12. doi: 10.1530/ERC-12-0227. Print 2013 Feb. Endocr Relat Cancer. 2013. PMID: 23111755
Cited by
-
Tamoxifen Rechallenge Decreases Metastatic Potential but Increases Cell Viability and Clonogenicity in a Tamoxifen-Mediated Cytotoxicity-Resistant Subline of Human Breast MCF7 Cancer Cells.Front Cell Dev Biol. 2020 Jun 30;8:485. doi: 10.3389/fcell.2020.00485. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32695778 Free PMC article.
-
The role of clonal communication and heterogeneity in breast cancer.BMC Cancer. 2019 Jul 5;19(1):666. doi: 10.1186/s12885-019-5883-y. BMC Cancer. 2019. PMID: 31277602 Free PMC article.
-
High-Throughput Cellular Heterogeneity Analysis in Cell Migration at the Single-Cell Level.Small. 2023 Feb;19(6):e2206754. doi: 10.1002/smll.202206754. Epub 2022 Nov 30. Small. 2023. PMID: 36449634 Free PMC article.
-
Generating Single Cell-Derived Knockout Clones in Mammalian Cells with CRISPR/Cas9.Curr Protoc Mol Biol. 2019 Sep;128(1):e100. doi: 10.1002/cpmb.100. Curr Protoc Mol Biol. 2019. PMID: 31503414 Free PMC article.
-
Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles.BMC Cancer. 2019 Apr 5;19(1):328. doi: 10.1186/s12885-019-5550-3. BMC Cancer. 2019. PMID: 30953488 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous